RPS6KB1 and cancer: S6K1 activity is controlled by the PI3K/Akt/mTOR signaling pathway, which has been shown to be dysregulated in diverse human pathologies, including diabetes, obesity, neurodegenerative disorders, and cancer (Tavareset al., 2015).